CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA. The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases. Read More
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31, 2020 (Q3FY21). ...
Share India Securities Limited, one of India's leading hi- tech broking Company and financial service provider, announced strong financial results for the quarter and year ended March 31st 2020. ...